GRFS

7.10

2.74% -0.20

Dopo l'orario di chiusura: 7.10

Grifols Sa Adr (GRFS)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Perché GRFS Giù? Forum Previsione Frazionamento azionario Storia dei dividendi

Precedente Chiudi:

$7.30

Aprire:

$7.22

Volume 24 ore:

1.19M

Relative Volume:

1.16

Capitalizzazione di mercato:

$5.00B

Reddito:

$7.94B

Utile/perdita netta:

$225.54M

Rapporto P/E:

21.52

EPS:

0.3299

Flusso di cassa netto:

$709.16M

1 W Prestazione:

-3.40%

1M Prestazione:

+2.45%

6M Prestazione:

-25.18%

1 anno Prestazione:

+2.31%

Intervallo 1D:

$7.09

$7.2769

Intervallo di 1 settimana:

$7.0807

$7.49

Portata 52W:

$5.79

$9.96

Grifols Sa Adr Stock (GRFS) Company Profile

Nome

Grifols Sa Adr

Settore

Healthcare (1153)

Industria

Drug Manufacturers - General (19)

Telefono

Indirizzo

Dipendente

23,822

Cinguettio

Prossima data di guadagno

2024-11-07

Ultimi documenti SEC

GRFS's Discussions on Twitter

Confronta GRFS con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
GRFS Grifols Sa Adr	7.10	5.00B	7.94B	225.54M	709.16M	0.3299
LLY Lilly Eli Co	734.57	739.39B	49.00B	11.11B	-1.27B	12.29
JNJ Johnson Johnson	154.22	375.64B	89.33B	21.81B	18.57B	8.99
ABBV Abbvie Inc	184.60	351.09B	57.37B	4.20B	17.83B	2.35
NVO Novo Nordisk Adr	65.77	307.32B	43.59B	15.04B	10.74B	3.3766
NVS Novartis Ag Adr	108.70	225.73B	53.22B	12.86B	14.85B	6.39

Grifols Sa Adr Stock (GRFS) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-02-12	Ripresa	Morgan Stanley	Overweight
2024-03-12	Downgrade	Deutsche Bank	Hold → Sell
2023-04-12	Aggiornamento	Morgan Stanley	Equal-Weight → Overweight
2023-03-03	Downgrade	Morgan Stanley	Overweight → Equal-Weight
2023-02-16	Aggiornamento	Barclays	Underweight → Equal Weight
2023-01-18	Aggiornamento	Jefferies	Hold → Buy
2022-04-08	Iniziato	Morgan Stanley	Equal-Weight
2021-11-05	Downgrade	Deutsche Bank	Buy → Hold
2021-10-19	Downgrade	Barclays	Overweight → Underweight
2021-10-06	Aggiornamento	Citigroup	Neutral → Buy
2021-06-14	Aggiornamento	Deutsche Bank	Hold → Buy
2021-04-20	Iniziato	Deutsche Bank	Hold
2021-03-23	Aggiornamento	Credit Suisse	Neutral → Outperform
2021-03-11	Aggiornamento	HSBC Securities	Hold → Buy
2020-10-01	Aggiornamento	Citigroup	Sell → Neutral
2020-06-09	Downgrade	Citigroup	Neutral → Sell
2020-06-09	Aggiornamento	HSBC Securities	Reduce → Hold
2020-03-25	Downgrade	Citigroup	Buy → Neutral
2019-06-27	Aggiornamento	JP Morgan	Neutral → Overweight
2019-02-08	Downgrade	Berenberg	Buy → Hold
2018-10-11	Aggiornamento	Berenberg	Hold → Buy
2018-06-01	Iniziato	Barclays	Overweight
2017-10-31	Iniziato	Citigroup	Buy
2017-06-30	Downgrade	Goldman	Buy → Neutral
2017-04-06	Iniziato	BofA/Merrill	Buy
2017-01-03	Aggiornamento	JP Morgan	Neutral → Overweight
2016-02-09	Aggiornamento	Berenberg	Hold → Buy
2016-01-04	Downgrade	Morgan Stanley	Equal-Weight → Underweight
2015-12-02	Downgrade	HSBC Securities	Buy → Hold
2015-11-20	Downgrade	Berenberg	Buy → Hold
2015-04-28	Downgrade	Berenberg	Buy → Hold

Mostra tutto

Grifols Sa Adr Borsa (GRFS) Ultime notizie

May 02, 2025

Grifols S.A. Investigated by Block & Leviton For Potential Securities Law Violations; Investors Who Have Lost Money Are Encouraged to Contact the Firm - ACCESS Newswire

May 02, 2025

Apr 28, 2025

SMRT’s latest rating updates from top analysts. - knoxdaily.com

Apr 28, 2025

Investing in Grifols SA ADR (GRFS): What You Must Know - knoxdaily.com

Apr 28, 2025

Investing in Apellis Pharmaceuticals Inc (APLS) Is Getting More Attractive - knoxdaily.com

Apr 28, 2025

A company insider recently sold 10,000 shares of News Corp [NWSA]. Should You also Consider to Sale? - knoxdaily.com

Apr 28, 2025

Raymond James Downgrades Truist Financial Corporation (TFC) to a Mkt perform from an Outperform - knoxdaily.com

Apr 28, 2025

AT&T, Inc (T) rating upgrades by Exane BNP Paribas - knoxdaily.com

Apr 28, 2025

Apr 25, 2025